Related Experiment Video
Updated: Jun 27, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Beta-cell autoimmunity in pediatric celiac disease: the case for routine screening?
Giuseppe d'Annunzio1, Alessandro Giannattasio, Elena Poggi
1Department of Pediatrics, University of Genoa, IRCCS G. Gaslini Institute, Genoa, Italy. giuseppedannunzio@ospedale-gaslini.ge.it
Diabetes Care
|November 20, 2008
Summary
Beta-cell autoimmunity is uncommon in children with celiac disease. Screening for type 1 diabetes is not recommended in this population due to low prevalence.
Area of Science:
- Endocrinology
- Gastroenterology
- Immunology
Background:
- Celiac disease (CD) is an autoimmune disorder.
- Type 1 diabetes (T1D) is also an autoimmune condition.
- Co-occurrence of CD and T1D is observed, suggesting shared autoimmune pathways.
Purpose of the Study:
- To determine the prevalence of beta-cell autoimmunity in pediatric celiac disease patients.
- To assess the utility of screening for type 1 diabetes in this cohort.
Main Methods:
- 188 young Italian patients with celiac disease were tested for GAD antibodies (GADAs), IA-2As, and IAAs.
- Celiac disease diagnosis was confirmed via jejunal biopsy and antibody testing.
- Patient data included age, sex, pubertal stage, family history, and other autoimmune disorders.
Main Results:
- GADAs were positive in 3.7% of patients; IA-2As in 1.1%. IAAs were negative in all cases.
- No patients developed diabetes during follow-up.
- No significant associations were found between beta-cell autoimmunity and demographic or clinical factors.
Conclusions:
- The prevalence of beta-cell autoimmunity is low in young patients with celiac disease.
- Precocious screening for beta-cell autoimmunity is not supported in this population.
- Further research may explore other autoimmune markers or risk stratification.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...